Soluble adhesion molecules in Finnish schoolchildren with signs of preclinical type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 20, Issue 1, 2004, Pages 48-54

  Toivonen, Anna ^a   Kulmala, Petri ^b   Rahko, Jukka ^b   Ilonen, Jorma ^c   Knip, Mikael ^a,d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoantibodies; First phase insulin response; HLA genotype; ICAM 1; L selectin; Prediction

Indexed keywords

AUTOANTIBODY; BIOCHEMICAL MARKER; CELL ADHESION MOLECULE; HLA DQB1 ANTIGEN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN;

ADOLESCENT; AGE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; FINLAND; GENETIC MARKER; GENOTYPE; HUMAN; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; INSULITIS; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; METABOLISM; PANCREAS ISLET DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; DIABETES MELLITUS, TYPE 1; FINLAND; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; PREDIABETIC STATE;

EID: 1042291964     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.418     Document Type: Article

References (37)

1. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
2. Damle NK, Klussman K, Linsley PS, Aruffo A. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3 and VCAM-1 on resting and antigen-primed CD+T lymphocytes. J Immunol 1992; 148: 1985-1992.
3. Hänninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 1901-1910.
4. Lepault F, Gagnerault MC. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 2000; 164: 240-247.
5. Balasa B, La Cava A, Van Gunst K, et al. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes. J Immunol 2000; 165: 7330-7337.
6. Tanaka T, Nakamur N, Kitagawa Y, et al. Prediction of diabetes in biobreeding/Aburahi rats by the measurement of soluble L-selectin. Autoimmunity 2000; 32: 101-107.
7. Lampeter ER, Kishimoto TK, Rothlein R, et al. Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Diabetes 1992; 41: 1668-1671.
8. Gearing AJ, Newman W. Circulating adhesion molecules in diseases. Immunol Today 1993; 14: 506-512.
9. Mysliwiec J, Kretowski A, Kinalski M, Kinalska I. CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects. Immunol Lett 1999; 70: 69-72.
10. Kretowski A, Gillespie KM, Bingley PJ, Kinalska I. Soluble L-selectin levels in type 1 diabetes mellitus: a surrogate marker for disease activity? Immunology 2000; 99: 320-325.
11. Toivonen A, Kulmala P, Savola K, Åkerblom HK, Knip M. The Childhood Diabetes in Finland Study Group. Soluble adhesion molecules in preclinical type 1 diabetes. Pediatr Res 2001; 49: 24-29.
12. Kulmala P, Rahko J, Savola K, et al. Stability of autoantibodies and their relation to genetic and metabolic markers of type 1 diabetes in initially unaffected schoolchildren. Diabetologia 2000; 43: 457-464.
13. Bingley PJ, Colman P, Eisenbarth GS, et al. Standardization of IVGTT to predict IDDM. Diabetes Care 1992; 15: 1313-1316.
14. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578-582.
15. Hjelm M. Enzymatic determination of hexoses in blood and urine. Scand J Clin Lab Invest 1966; 18(92): 85-98.
16. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279-1282.
17. Greenbaum CJ, Palmer JP, Nagataki S, et al. improved specificity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes 1992; 41: 1570-1574.
18. Sabbah E, Kulmala P, Veijola R, et al. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab 1996; 81: 2455-2459.
19. Savola K, Bonifacio E, Sabbah E, et al. IA-2 antibodies-a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 1998; 41: 424-429.
20. Bingley PJ, Bonifacio E, Mueller P. Participating laboratories: diabetes antibody standardisation programme: first assay proficiency evaluation. Diabetes 2003; 52: 1128-1136.
21. Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA. A novel micro-assay for insulin autoantibodies. J Autoimmun 1997; 10: 473-478.
22. Sjöroos M, Iitiä A, Ilonen J, Reijonen H, Lövgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 1995; 18: 870-877.
23. Ilonen J, Reijonen H, Herva E, et al. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 1996; 19: 79S-800.
24. Sjöroos M, Ilonen J, Reijonen H, Lövgren T. Time-resolved fluorometry based sandwich hybridization assay for HLA-DQA1 typing. Dis Markers 1998; 14: 9-19.
25. Tuomilehto J, Karvonen M, Pitkäniemi J, et al., The Finnish Childhood Type 1 Diabetes Registry Group. Record-high incidence of type 1 (insulin-dependent) diabetes mellitus in Finnish children. Diabetologia 1999; 42: 655-660.
26. Veijola R, Reijonen H, Vähäsalo P, et al. HLADQB1 defined genetic susceptibility, beta-cell autoimmunity and metabolic characteristics in familial and non-familial insulin-dependent diabetes mellitus. J Clin Invest 1996; 98: 2489-2495.
27. Komulainen J, Kulmala P, Savola K, et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Diabetes Care 1999; 22: 1950-1955.
28. Sabbah E, Savola K, Ebeling T, et al. Genetic, autoimmune, and clinical characteristics of childhood and adult onset type 1 diabetes. Diabetes Care 2000; 23: 1326-1332.
29. Kulmala P, Savola K, Petersen JS, et al., The Childhood Diabetes in Finland Study Group. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. J Clin Invest 1998; 101: 327-336.
30. LaGasse JM, Brantley MS, Leech NJ, et al. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies. An 8-year follow-up of the Washington state diabetes prediction study. Diabetes Care 2002; 25: 505-511.
31. Sabbah E, Savola K, Kulmala P, et al. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. J Clin Endocrinol Metab 1999; 84: 1534-1539.
32. Kulmala P, Savola K, Reijonen H, et al. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Diabetes 2000; 49: 48-58.
33. Kimpimäki T, Kupila A, Hämäläinen A-M, et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish type 1 diabetes prediction and prevention study. J Clin Endocrinol Metab 2001; 86: 4782-4788.
34. Sabbah E, Savola K, Kulmala P, et al. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). Clin EXP Immunol 1999; 116: 78-83.
35. Bingley PJ. The ICARUS Group. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+relatives. Diabetes 1996; 45: 1720-1728.
36. Greenbaum CJ, Sears KL, Kahn SE, Palmer JP. Relationship of beta-cell function and autoantibodies to progression and non-progression of subclinical type 1 diabetes. Follow-up of the Seattle family study. Diabetes 1999; 48: 170-175.
37. Schleiffenbaum B, Spertini O, Tedder T. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992; 119: 229-238.